Erythema dyschromicum perstans

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

Erythema dyschromicum perstans
Grayish macules affecting the neck, trunk, and back
Synonyms	Ashy dermatosis
Pronounce	N/A
Specialty	Dermatology
Symptoms	Grayish or bluish macules on the skin
Complications	N/A
Onset	Usually in adulthood
Duration	Chronic
Types	N/A
Causes	Unknown, possibly autoimmune or environmental factors
Risks	More common in Hispanic and Asian populations
Diagnosis	Clinical diagnosis, skin biopsy
Differential diagnosis	Lichen planus, post-inflammatory hyperpigmentation, fixed drug eruption
Prevention	N/A
Treatment	Topical corticosteroids, tacrolimus, phototherapy
Medication	N/A
Prognosis	Variable, often persistent
Frequency	Rare
Deaths	N/A

Erythema Dyschromicum Perstans (EDP), also known as Ashy Dermatosis, is a rare skin condition characterized by the development of gray to blue-brown macules and patches on the skin. The etiology of EDP remains largely unknown, but it is thought to involve a combination of genetic, environmental, and immunological factors. This condition is more commonly observed in individuals with darker skin types and is prevalent in Latin American countries, though it can affect individuals of any ethnic background.

Symptoms and Diagnosis

The primary symptom of Erythema Dyschromicum Perstans is the appearance of ashy-gray to blue-brown patches on the skin, which can vary in size and shape. These patches are usually well-demarcated and can appear anywhere on the body, but they are most commonly found on the trunk, neck, and extremities. The lesions are typically asymptomatic, but some patients may experience mild itching. Diagnosis of EDP is primarily clinical, based on the characteristic appearance of the skin lesions. A Dermoscopy and skin biopsy may be performed to rule out other conditions and confirm the diagnosis. Histopathological examination of a biopsy sample typically shows a lymphohistiocytic infiltrate in the upper dermis and increased melanin in the basal layer of the epidermis.

Treatment

There is no definitive cure for Erythema Dyschromicum Perstans, and treatment is primarily aimed at managing symptoms and improving the appearance of the skin lesions. Treatment options may include topical steroids, Tretinoin (a form of vitamin A), and Clofazimine. In some cases, laser therapy or chemical peels may be used to lighten the patches. However, the effectiveness of these treatments can vary, and there is a risk of the skin condition worsening or relapsing.

Epidemiology

Erythema Dyschromicum Perstans can affect individuals of any age, but it most commonly presents in young adults. There is no known gender predilection. While cases have been reported worldwide, there is a higher prevalence in individuals from Latin America and those with darker skin types.

Pathophysiology

The exact pathophysiology of Erythema Dyschromicum Perstans is not well understood. It is believed to involve a combination of genetic predisposition, environmental triggers, and immune system dysregulation. Some theories suggest that EDP may be a type of lichenoid dermatitis, where an immune response leads to inflammation and subsequent changes in skin pigmentation.

Prognosis

The prognosis for individuals with Erythema Dyschromicum Perstans is generally good, as the condition is not life-threatening and does not affect overall health. However, the cosmetic appearance of the skin lesions can be a significant concern for patients, potentially leading to psychological distress and a decreased quality of life.

See Also

• Lichen Planus
• Post-inflammatory Hyperpigmentation
• Vitiligo

   This article is a medical stub. You can help WikiMD by expanding it!